Regeneron Pharmaceuticals Modification Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Modification No. 03 to Project Agreement, dated as of May 21, 2021, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 06 to Project Agreement, dated as of July 12, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 04 to Project Agreement, dated as of July 12, 2021, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 02 to Base Agreement, dated as of August 2, 2022, by and between Regeneron Pharmaceuticals, Inc. (the "Registrant") and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 0
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 5 to Project Agreement, dated as of March 22, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 1 to Base Agreement, dated as of January 26, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 02 to Project Agreement, dated as of November 17, 2020, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Modification No. 01 to Project Agreement, dated as of October 13, 2020, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2021